Vaccines to Watch in 2024
Drug Topics
MARCH 19, 2024
Moderna, Merck, and Pfizer-BioNTech are leading the charge with new vaccines for respiratory viruses in development.
Tue.Mar 19, 2024
498 
GSK has the U.S. shingles vaccine market cornered. A jab with fewer side effects could change that.
PharmaVoice
MARCH 19, 2024
Curevo Vaccine is readying a phase 3 trial for a candidate it believes could have an edge over GSK’s blockbuster Shingrix.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Novavax COVID-19 Vaccine Shows Lasting Protection Against Delta Variant
Drug Topics
MARCH 19, 2024
The biotechnology company’s recombinant spike protein-based vaccine demonstrated an efficacy of 88% after 40 days, 82% after 120 days, and 77% after 180 days during the PREVENT-19 trial.
A study says intermittent fasting is making people drop dead. Oh, come on
STAT
MARCH 19, 2024
The news is everywhere in my social news feeds this morning: A popular fad diet is apparently lethal, scientific research says. Specifically, a study found that caloric restriction, also known as intermittent fasting, has a 91% risk of death due to cardiovascular disease. Except scientific research doesn’t say that — and not only should you not be worried about this study, you shouldn’t be wasting brain glucose thinking about it.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacist Education, Knowledge Key to Fostering Biosimilar Adoption
Drug Topics
MARCH 19, 2024
Despite the significant growth of biosimilars, their adoption across various therapeutic areas has remained slow.
Opinion: The evidence is clear: A liquid-only diet before a colonoscopy is unnecessary
STAT
MARCH 19, 2024
Since colorectal cancer is on the rise in people younger than age 50, national guidelines have recently pushed the starting age for colorectal cancer screening down to 45. We need to spread the word. Yet we specialists continue to provide outdated and disproven recommendations on colonoscopy bowel preparation that make the process more difficult for the millions of patients who undergo colonoscopy every year: We tell them to adopt a clear liquid diet the day before their procedure.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform
STAT
MARCH 19, 2024
Private equity firms have acquired stakes in nearly one-third of all methadone clinics in recent years, gaining outsize control of the U.S. addiction treatment industry even as the country’s opioid epidemic has developed into a full-fledged public health crisis. A small handful of little-known financial institutions now has an ownership stake in 562 methadone clinics across the country, according to a first-of-its-kind STAT analysis.
Google's healthcare AI ambitions: New model for personal health coaching and next steps for gen AI
Fierce Healthcare
MARCH 19, 2024
Google is doubling down on its ambitions for healthcare AI by exploring how generative AI can help clinicians in medical decision-making, understand lab and imaging information and provide con | Google is hyper-focused on generative AI in healthcare, pushing forward research to advance gen AI capabilities that can help clinicians in medical decision-making, understand lab and imaging information and provide consumers with personalized health insights based on their wearable data.
STAT+: As targeted radiation field heats up, AstraZeneca to pick up Fusion Pharmaceuticals in $2 billion deal
STAT
MARCH 19, 2024
LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer. AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday.
Hippocratic AI banks $53M backed by General Catalyst, a16z, Memorial Hermann, UHS and other health systems
Fierce Healthcare
MARCH 19, 2024
Launched out of stealth about a year ago, Hippocratic AI launched its first generative AI product and pocketed $53 million in series A funding, the startup announced Monday. | Launched out of stealth about a year ago, Hippocratic AI launched its first generative AI product and pocketed $53 million in series A funding. The fresh funding boosts the company's valuation to $500 million.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: UnitedHealth appears to be upping loan offers to providers, after Change cyberattack
STAT
MARCH 19, 2024
UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures. The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing.
Google Health, Stanford Medicine unveil open-access dataset of diverse dermatology images
Fierce Healthcare
MARCH 19, 2024
Google Health unveiled an open-access dataset of real-world dermatology images in partnership with Stanford Medicine. | Thousands of people contributed their images of skin, hair and nail conditions to the Skin Condition Image Network (SCIN) for a diverse dataset reflecting various skin tones, ages, settings and condition severities.
STAT+: Q&A: Mark Parrino says it’s time to ‘completely re-examine’ methadone treatment for opioid addiction
STAT
MARCH 19, 2024
Nobody has made more of an impact on methadone treatment than Mark Parrino. For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.
CDC releases field-tested guidance for hospital CEOs tackling their workers' mental health
Fierce Healthcare
MARCH 19, 2024
The Centers for Disease Control and Prevention (CDC)’s campaign against healthcare worker burnout took a step forward this week with the release of a new instructional guide for executive-level hos | The free resource was developed alongside the Dr. Lorna Breen Heroes' Foundation and informed by a six-month, six-hospital pilot across CommonSpirit Health facilities.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Riding GLP-1 wave, Novo Nordisk lays out $560M to boost drug production in China
Fierce Pharma
MARCH 19, 2024
This year marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the company's red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nat | 2024 marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the Danish drugmaker’s red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nation.
Elevance Health to acquire Kroger Specialty Pharmacy
Fierce Healthcare
MARCH 19, 2024
Elevance Health has inked a deal to acquire Kroger Specialty Pharmacy. | The grocery chain announced Monday that an agreement is in place, saying it's expected to close in the back half of 2024 pending regulatory approvals.
Do better: The message to the industry from an analysis of clinical evidence submitted to NICE over 20 years
pharmaphorum
MARCH 19, 2024
Do better: The message to the industry from an analysis of clinical evidence submitted to NICE over 20 years Mike.
As investors ‘lose trust’ in pharma’s business model, focused M&A strategies can help
PharmaVoice
MARCH 19, 2024
A rebound in M&A seems to be on the docket, but analysts are warning companies to be intentional about where they go with it.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Glucophage Activates the Same Pathway as Sprint Exercise to Reduce Appetite
Pharmacy Times
MARCH 19, 2024
The oral medication activates an “anti-hunger” molecule which may prevent people from overeating.
Improving patient engagement and drug development through AI and enhanced medical affairs roles
pharmaphorum
MARCH 19, 2024
Learn how AI and enhanced medical affairs roles are transforming the landscape of drug development and patient engagement in the health industry. Explore the benefits and advancements in this exciting field.
FDA Approves Expanded Indications for Spesolimab-sbzo Injection for the Treatment of Generalized Pustular Psoriasis
Pharmacy Times
MARCH 19, 2024
To date, this is the only targeted therapy indicated for the treatment of generalized pustular psoriasis.
STAT+: In small study, baby aspirin cuts fat buildup in liver disease patients
STAT
MARCH 19, 2024
Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found. The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD.
The unmentionables: Challenging inequalities in women’s health
pharmaphorum
MARCH 19, 2024
As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too.
STAT+: Pharmalittle: We’re reading about an AstraZeneca deal, a WHO pandemic pact, and more
STAT
MARCH 19, 2024
Rise and shine, everyone, another busy day is on the way. Already, the official mascots are racing about the Pharmalot campus in search of breakfast and a steady stream of traffic can be heard nearby. As for us, we are engaged in the usual rituals, starting with brewing cups of stimulation. Our choice today is salted caramel, a veritable whiff of the Jersey shore.
Pharmacists Can Enhance Hypertension Control Through Team-Based Approaches
Pharmacy Times
MARCH 19, 2024
Team-based care models improve continuity of care and accessibility for patients.
Managing the challenges and embracing the opportunities of EU-wide HTA
pharmaphorum
MARCH 19, 2024
Discover the key strategies for managing the challenges and embracing the opportunities of EU-wide Health Technology Assessment (HTA) in partnership with the European Medicines Agency (EMA) and prospective market authorisation holders (pMAHs).
NVIDIA doubles down on AI in healthcare with drug discovery deals
Pharmaceutical Technology
MARCH 19, 2024
In addition to drug discovery deals, NVIDIA also announced partnerships with J&J MedTech and GE Healthcare for genAI in MedTech.
AZ agrees $2bn deal to buy radiopharma firm Fusion
pharmaphorum
MARCH 19, 2024
AstraZeneca upgrades its radiopharma alliance with Fusion Pharma, opting to buy the biotech outright in a deal worth around $2 billion
Biden’s administration initiative aims to advance women’s health conditions
Pharmaceutical Technology
MARCH 19, 2024
The new initiative aims to spur innovation and mobilisation of sectors to drive women’s health research.
Match Day 2024: Record number of applicants, residency positions
Fierce Healthcare
MARCH 19, 2024
The upcoming crop of soon-to-be physicians learned on Friday where they would spend their residencies. Match Day 2024 saw record-high applicants and residency positions offered. | The upcoming crop of soon-to-be physicians learned on Friday where they would spend their residencies. Match Day 2024 saw record-high applicants and residency positions offered.
Wegovy and Zepbound get primetime treatment
STAT
MARCH 19, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at a pioneering new gene therapy, the plight of WuXi AppTec, and a rough month for biotech’s neuroscience renaissance.
Bayer cues up filings for rival to Astellas’ menopause drug
pharmaphorum
MARCH 19, 2024
New phase 3 data sets up filings for Bayer's non-hormonal menopause symptom treatment elinzanetant and a challenge to Astellas’ first-to-market Veozah
Novartis acquisition to address inflammation-driven diseases
European Pharmaceutical Review
MARCH 19, 2024
Under a new deal, Novartis has agreed to acquire US-based biopharma company IFM Therapeutics, for a total of up to $835 million. As part of this new agreement, Novartis has exercised its option to acquire all outstanding capital stock of IFM Due, a subsidiary company of IFM. Therefore, under the acquisition, Novartis has full rights to IFM Due’s portfolio of small molecule Stimulator of Interferon Genes (STING) antagonists, IFM confirmed.
Let's personalize your content